Literature DB >> 32676895

Impact of adjuvant therapy toxicity on quality of life and emotional symptoms in patients with colon cancer: a latent class analysis.

D Gomez1, C Calderón2, A Carmona-Bayonas3, D Cacho Lavin4, M M Muñoz5, R Martinez Cabañez6, P Jimenez-Fonseca7.   

Abstract

OBJECTIVE: To identify distinct trajectories of toxicity in colorectal cancer (CRC) patients after adjuvant chemotherapy and its impact on quality of life (QoL) and psychological symptoms.
METHODS: A prospective, multicenter study was conducted in 157 patients. A latent class analysis defined the unobserved latent constructs that can be predicted as symptom clusters, considering the intensity of four types of adverse events (AEs). Patients completed EORTC-QLQ-C30, BSI-18, PDRQ-9, and DRS scales.
RESULTS: Ninety-six percent had some degree of toxicity, with grades 3-4 being the most common: neurotoxicity (7.2%), hematological (13.1%), digestive (5.2%), and skin toxicity (1.4%). Three distinct latent classes were identified (high [72.5%], mild [16.9%], and low [10.6%] toxicity). Patients with high toxicity had the worst QoL scores and moderately high somatization and psychological distress scores.
CONCLUSIONS: Adjuvant chemotherapy for CRC was associated with frequent toxicity that negatively impacted QoL and psychological wellbeing.

Entities:  

Keywords:  Adjuvant treatment; Cancer; Latent class analysis; Oxaliplatin; Toxicity; Trajectory analysis

Year:  2020        PMID: 32676895     DOI: 10.1007/s12094-020-02454-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  2 in total

Review 1.  Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.

Authors:  Christina Teng; Jordan Cohen; Sam Egger; Prunella L Blinman; Janette L Vardy
Journal:  Support Care Cancer       Date:  2021-08-19       Impact factor: 3.603

2.  SFMBT1 facilitates colon cancer cell metastasis and drug resistance combined with HMG20A.

Authors:  Ruijun Pan; Dingye Yu; Jiajia Hu; Xiao Yang; Chenxing Wang; Luyang Zhang; Pei Xue; Jing Sun; Xiaoping Zhang; Wei Cai
Journal:  Cell Death Discov       Date:  2022-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.